| Domaine : |
 |
Sciences du Vivant/Médecine humaine et pathologie
|
|
PMID (identifiant
de la référence Pubmed) : |
|
 (12869355) |
|
| Titre : |
|
Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial. |
|
| Auteur(s) : |
|
Emmanuel Oger1, Martine Alhenc-Gelas2, Karine Lacut1, Marie-Thérèse Blouch1, 3, Nathalie Roudaut4, Véronique Kerlan1, 4, Michel Collet1, 5, Jean-François Abgrall3, Martine Aiach2, Pierre-Yves Scarabin6, Dominique Mottier1, |
|
| Laboratoire : |
|
|
|
| Résumé : |
|
OBJECTIVE: Activated protein C (APC) resistance not related to the factor V Leiden mutation is a risk factor for venous thrombosis. Oral estrogen replacement therapy (ERT) has been reported to induce APC resistance. Little is known about the effect of transdermal estrogen. METHODS AND RESULTS: We enrolled 196 postmenopausal women who were randomly allocated to receive either 1 mg 17beta-estradiol orally (n=63) or 50 microg 17beta-estradiol transdermally per day (n=68), both associated with 100 mg progesterone daily or placebo (n=65) for 6 months. An activated partial thromboplastin time (APTT)-based test and the effect of APC on thrombin potential (ETP) were used. Oral ERT induced an ETP-based APC resistance compared with both placebo (P=0.006) and transdermal ERT (P<0.001), but there was no significant effect of transdermal ERT compared with placebo (P=0.191). There was no significant effect of ERT on the APTT-based APC sensitivity ratio. Prothrombin fragment 1+2 plasma levels were significantly higher after 6 months of treatment in women allocated to oral ERT compared with those on placebo and transdermal ERT and were positively and significantly correlated with changes in ETP-based APC sensitivity ratio. CONCLUSIONS: Our data show that oral, unlike transdermal, estrogen induces APC resistance and activates blood coagulation. These results emphasize the importance of the route of estrogen administration. |
|
Langue du texte
intégral : |
|
Anglais |
|
|
| Type de publication : |
|
Articles dans des revues avec comité de lecture |
|
| DOI : |
|
10.1161/01.ATV.0000087141.05044.1F |
|
| Journal : |
|
| Arteriosclerosis, Thrombosis, and Vascular Biology (Arterioscler Thromb Vasc Biol) |
| Publisher |
American Heart Association |
| ISSN |
1079-5642 (eISSN : 1524-4636) |
|
|
| Audience : |
|
internationale |
|
| Date de publication : |
|
01/09/2003 |
|
Date de publication
électronique : |
|
17/07/2003 |
|
| Volume : |
|
23 |
|
| Numéro : |
|
9 |
|
| Page, identifiant, ... : |
|
1671-6 |
|
|
| Descripteur(s) MeSH : |
|
Administration – Cutaneous – Administration – Oral – Estrogens – Female – Humans – Postmenopause – Progesterone – Protein C |
|
|
